Association between microfilarial load and excess mortality in onchocerciasis: An epidemiological study

Lancet

Volumn 363, Issue 9420, 2004, Pages 1514-1521

  Little, M P ^a,c   Breitling, L P ^a   Basanez M G ^a   Alley, E S ^b   Boatin, B A ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICA; ARTICLE; BLINDNESS; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEALTH PROGRAM; HOST; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MICROFILARIA; MORTALITY; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PRIORITY JOURNAL; SEX DIFFERENCE; VISUAL ACUITY;

EID: 2342655094     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16151-5     Document Type: Article

References (39)

1. Prost A, Vaugelade J. La surmortalité des aveugles en zone de savane ouest-africaine (in French). Bull World Health Organ. 59:1981;773-776
2. Kirkwood B, Smith P, Marshall T, Prost A. Relationships between mortality, visual acuity and microfilarial load in the area of the Onchocerciasis Control Programme. Trans R Soc Trop Med Hyg. 77:1983;862-868
3. Prost A. The burden of blindness in adult males in the savanna villages of West Africa exposed to onchocerciasis. Trans R Soc Trop Med Hyg. 80:1986;525-527
4. Hall LR, Pearlman E. Pathogenesis of onchocercal keratitis (river blindness). Clin Microbiol Reviews. 12:1999;445-453
5. Pearlman E, Hall LR. Immune mechanisms in Onchocerca volvulus-mediated corneal disease (river blindness). Parasite Immunol. 22:2000;625-631
6. Saint André A, Blackwell NM, Hall LR, et al. The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science. 295:2002;1892-1895
7. Habbema JDF, van Oortmarssen GJ, Plaisier AP. The ONCHOSIM model and its use in decision support for river blindness control. Isham V, Medley G. Models for infectious human diseases. Their structure and relation to data. 1996;360-380 Publications of the Newton Institute, Cambridge University Press, Cambridge
8. Evans TG. Socioeconomic consequences of blinding onchocerciasis in West Africa. Bull World Health Organ. 73:1995;495-506
9. WHO. Report of a WHO Expert Committee on Onchocerciasis Control. Onchocerciasis and its control. WHO technical report series. 1995;World Health Organization, Geneva
10. Molyneux DH. Onchocerciasis control in West Africa: current status and future of the Onchocerciasis Control Programme. Parasitol Today. 11:1995;399-402
11. Molyneux DH, Davies JB. Onchocerciasis control: moving towards the millennium. Parasitol Today. 13:1997;418-425
12. Hougard J-M, Alley ES, Yaméogo L, Dadzie KY, Boatin BA. Eliminating onchocerciasis after 14 years of vector control: a proved strategy. J Infect Dis. 184:2001;497-503
13. Dietz K. The population dynamics of onchocerciasis. Anderson RM. Population dynamics of infectious diseases. 1982;209-241 Chapman and Hall, London
14. Basáñez M-G, Ricárdez-Esquinca J. Models for the population biology and control of human onchocerciasis. Trends Parasitol. 17:2001;430-438
15. Prost A, Thylefors B, Pairault C. Methods of mass epidemiological evaluation of onchocerciasis. Their utilization in a vector control programme. Document ONCHO/WP/75·14. 1975;World Health Organization, Geneva
16. Thylefors B. Vision screening of illiterate populations. Bull World Health Organ. 55:1977;115-119
17. Moreau JP, Prost A, Prod'hon J. Essai de normalisation de la méthodologie des enquêtes clinico-parasitologiques sur l'onchocercose en Afrique de l'Ouest. Méd Trop (Mars). 38:1978;43-51
18. Prost A, Prod'hon J. Le diagnostique de l'onchocercose. Revue critique des méthodes en usage. Méd Trop (Mars). 38:1978;519-532
19. Prost A, Gorim De Ponsay E. Importance epidemiologique du parasitism neo-natal par microfilaires d'Onchocerca volvulus. Tropenmed Parasitol. 30:1979;477-481
20. Duerr HP, Dietz K, Eichner M. On the interpretation of age-intensity profiles and dispersion patterns in parasitological surveys. Parasitology. 126:2003;87-101
21. Little MP, Basáñez M-G, Breitling LPh, Boatin BA, Alley ES. Incidence of blindness during the Onchocerciasis Control Programme in Western Africa, 1971-2002. J Infect Dis (in press).
22. Breslow NE, Day NE. Statistical methods in cancer research. Volume II - the design and analysis of cohort studies. IARC Scientific Publications no 82, Lyon: IARC, 1987.
23. McCullagh P, Nelder JA. Generalized linear models. 2nd edn :1989;Chapman and Hall, London
24. S-Plus. S-Plus 6·0 Professional Release 2 for Windows. Seattle: Insightful, 2001.
25. Remme J, Dadzie KY, Rolland A, Thylefors B. Ocular onchocerciasis and intensity of infection in the community. I. West African savanna. Trop Med Parasitol. 40:1989;340-347
26. Pion SDS, Kamgno J, Demanga-Ngangue, Boussinesq M. Excess mortality associated with blindness in the onchocerciasis focus of the Mbam Valley, Cameroon. Ann Trop Med Parasitol. 96:2002;181-189
27. Steel C, Nutman TB. Regulation of IL-5 in onchocerciasis. A critical role for IL-2. J Immunol. 12:1993;5511-5518
28. Ottesen EA. Immune responsiveness and the pathogenesis of human onchocerciasis. J Infect Dis. 171:1995;659-671
29. h2 shift. Int Immunol. 12:2000;623-630
30. Hoerauf A, Brattig N. Resistance and susceptibility in human onchocerciasis - beyond Th1 vs Th2. Trends Parasitol. 18:2002;25-31
31. Satoguina J, Mempel M, Larbi J, et al. Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis). Microbes Infect. 4:2002;1291-1300
32. Cooper PJ, Espinel I, Paredes W, Guderian RH, Nutman TB. Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human onchocerciasis: a possible role for interleukin-10. J Infect Dis. 178:1998;1133-1138
33. Kipp W, Kasoro S, Burnham G. Onchocerciasis and epilepsy in Uganda. Lancet. 343:1994;183-184
34. Newell ED, Vyungimana F, Bradley JE. Epilepsy, retarded growth and onchocerciasis, in two areas of different endemicity of onchocerciasis in Burundi. Trans R Soc Trop Med Hyg. 91:1997;525-527
35. Duke BOL. Onchocerciasis, epilepsy and hyposexual dwarfism. Trans R Soc Trop Med Hyg. 92:1998;236
36. Burnham GM. Onchocerciasis in Malawi. 2. Subjective complaints and decreased weight in persons infected with Onchocerca volvulus in the Thyolo highlands. Trans R Soc Trop Med Hyg. 85:1991;497-500
37. Richards FO Jr, Boatin B, Sauerbrey M, Sékétéli A. Control of onchocerciasis today: status and challenges. Trends Parasitol. 17:2001;558-653
38. Preston SH. Mortality and development revisited. Popul Bull UN. 18:1985;34-40
39. Borsboom GJJM, Boatin BA, Nagelkerke NJD, et al. Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa. Filaria J. 2:(8):2003;1-25